Corrigendum: Therapeutic potential of topical administration of acriflavine against hypoxia-inducible factors for corneal fibrosis.

Zhu, Shuyan; Shan, Huimin; Li, Jianqiao; Pan, Lijie; Wang, Shudan; Zhu, Jing; Guo, Hui; Mi, Fenghua; Wu, Xinyi; Yin, Jia; Pang, Kunpeng.

Afiliación

Zhu S; Xi'an People's Hospital (Xi'an Fourth Hospital), Shanxi Eye Hospital, Xi'an, China.
Shan H; Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Li J; Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Pan L; Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Wang S; Department of Ophthalmology, Harvard Medical School, Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, MA, United States.
Zhu J; Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Guo H; Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Mi F; Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Wu X; Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Yin J; Department of Ophthalmology, Harvard Medical School, Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, MA, United States.
Pang K; Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.